This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a pyrrolidine ring and difluorophenyl group, makes it valuable in the development of drugs targeting central nervous system disorders, such as antidepressants and antipsychotics. Additionally, it is employed in the creation of compounds with potential antifungal and antibacterial properties, contributing to the advancement of novel therapeutic agents. Its chiral nature also allows for its use in asymmetric synthesis, enhancing the efficiency and specificity of drug development processes.